Abstract
A high survival rate of grafted dopamine neurons is crucial for reversing neurological deficits following brain tissue transplantation in Parkinson's disease. For unknown reasons the survival rate of transplanted dopamine neurons is only around 10% in experimental animals. The hypothesis that oxidative stress causes the loss of transplanted neurons was tested by grafting neurons from transgenic mice that overexpress Cu/Zn superoxide dismutase. Compared with the survival of those taken from non-transgenic littermates, the survival was 4 times higher for the transgenic dopamine neurons with a concomitant more extensive functional recovery. The results provide direct support for the free radical hypothesis of dopaminergic neuron death in brain tissue grafting.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lindvall, O. Neural transplantation in Parkinson's disease. in Functional Neural Transplantation (eds. Dunnett, S.B & Bj¨rklund, A.) 103–137 (Raven Press, New York, 1994).
Sauer, H. & Brundin, P. Effects of cool storage on survival and function of in-trastriatal ventral mesencephalic grafts. Restor. Neurol. Neurosci. 2, 123–135 (1991).
Brundin, P. et al. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp. Brain Res. 70, 192–208 (1988).
Frodl, E.M., Duan, W.-M., Sauer, H., Kupsch, A. & Brundin, P. Human embryonic dopamine neurons xenografted to the rat: Effects of cryopreservation and varying regional source of donor cells on transplant survival, morphology and function. Brain Res. 647, 286–298 (1994).
Nakao, N., Frodl, E.M., Duan, W.-M., Widner, H. & Brundin, P. Lazaroids improve the survival of grafted rat embryonic dopaminergic neurons. Proc. natn. Acad. Sci. U.S.A. 91, 12408–12412 (1994).
Duan, W.-M., Widner, H. & Brundin, P. Temporal pattern of host response against intrastriatal grafts of syngeneic, allogeneic or xenogeneic embryonic neuronal tissue in rats. Exp. Brain Res., in the press.
Hall, E.D. & Braughler, J.M. Central nervous system trauma and stroke: II. Physiological and pharmacological evidence for the involvement of oxygen radicals and lipid peroxidation. Free Rad. Biol. Med. 6, 303–313 (1989).
Siesjö, B.K., Aghardh, C.-D. & Bengtsson, F. Free radicals and brain damage. Cereb. Brain Metab. Rev. 1, 165–211 (1989).
Olanow, C.W. A radical hypothesis for neurodegeneration. Trends Neurosci. 16, 439–444 (1994).
Coyle, J.T. & Puttfarcken, P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689–694 (1993).
Epstein, C.J. et al. Transgenic mice with increased CuZn-superoxide dismutase activity: an animal model of dosage effects in Down syndrome. Proc. natn. Acad. Sci. U.S.A. 84, 8044–8048 (1987).
Fridovich, I. Superoxide dismutases. Adv. Enzym. 58, 61–97 (1986).
Przedborski, S. et al. Superoxide dismutase, catalase, and glutathione peroxidase activities in copper/zinc-superoxide dismutase transgenic mice. J. Neurochem. 58, 1760–1767 (1992).
Cadet, J.L. et al. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 62, 380–383 (1994).
Kinouchi, H. et al. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn Superoxide dismutase. Proc. natn. Acad. Sci. U.S.A. 88, 11158–11162 (1992).
Przedborski, S. et al. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J. Neurosci. 12, 1658–1667 (1992).
Baker, H., Joh, T.H. & Reis, D.J. Genetic control of number of midbrain dopaminergic neurons in inbred strains of mice: Relationship to size and neuronal density of the striatum. Proc. natn. Acad. Sci. U.S.A. 77, 4369–4373 (1980).
German, D.C., Schlusselberg, D.S. & Woodward, D.J. Three-dimensional computer reconstruction of midbrain dopaminergic neuronal populations: From mouse to man. J. Neural Transm. 57, 243–254 (1983).
Triarhou, L.C., Norton, J. & Ghetti, B. Mesencephalic dopamine cell deficit involves areas A8, A9 and A10 in weaver mutant mice. Exp. Brain Res. 70, 256–265 (1988).
Chadi, G. et al. Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion. Exp. Brain Res. 97, 145–158 (1993).
Dexter, D.T. et al. Nigral dopaminergic cell loss in vitamin E deficient rats. NeuroReport 5, 1773–1776 (1994).
Dexter, D.T. et al. Nigrostriatal function in vitamin E deficiency: Clinical, experimental, and positron emission tomographic studies. Ann. Neurol. 35, 298–303 (1994).
Oppenheim, R.W. Cell death during development of the nervous system. Annu. Rev. Neurosci. 14, 453–501 (1991).
Mahalik, T.J., Hahn, W.E., Clayton, G.H. & Owens, G.P. Programmed cell death in developing grafts of fetal substantia nigra. Exp. Neurol. 129, 27–36 (1994).
Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A. & Freeman, B.A. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. natn. Acad. Sci. U.S.A. 87, 1620–1624 (1990).
Lipton, S.A. et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364, 626–632 (1993).
Huang, Z. et al. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265, 1883–1885 (1994).
Rosen, D.R. et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familiar amyotrophic lateral sclerosis. Nature 362, 59–62 (1993).
Deng, H.-X. et al. Amyotrophic lateral sclerosis and structural defects in CuZn superoxide dismutase. Science 261, 1047–1051 (1993).
Gurney, M.E. et al. Motor neuron degeneration in mice that express a human CuZn superoxide dismutase mutation. Science 264, 1772–1775 (1994).
Sofic, E., Paulus, W., Jellinger, K., Riederer, P. & Youdium, M.B.H. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J. Neurochem. 56, 978–982 (1991).
Dexter, D.T. et al. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 52, 1830–1836 (1989).
Riederer, P. et al. Transition metals, ferritin, glutathione, ascorbic acid in parkinsonian brains. J. Neurochem. 52, 515–520 (1989).
Sian, J. et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36, 348–355 (1994).
Dexter, D.T. et al. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52, 381–389 (1989).
Lieman-Hurwitz, J., Dafni, N., Lavie, V. & Groner, Y. Human cytoplasmic superoxide dismutase cDNA clone: A probe for studying the molecular biology of Down syndrome. Proc. natn. Acad. Sci. U.S.A. 79, 2808–2811 (1982).
Brundin, P., Isacson, O. & Björklund, A. Monitoring of cell viability in suspension of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res. 331, 251–259 (1985).
Ungerstedt, U. & Arbuthnott, G.W. Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 24, 486–493 (1970).
Schmidt, R.H., Björklund, A., Stenevi, U., Dunnett, S.B. & Gage, F.H. Intracerebral grafting of neuronal cell suspensions. III. Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism. Acta. physiol. scand. Suppl. 522, 19–28 (1983).
Abercrombie, M. Estimation of nuclear population from microtome sections. Anat. Rec. 94, 239–247 (1946).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakao, N., Frodl, E., Widner, H. et al. Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nat Med 1, 226–231 (1995). https://doi.org/10.1038/nm0395-226
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0395-226
This article is cited by
-
Single-atom nanozymes towards central nervous system diseases
Nano Research (2023)
-
Recent advances in small molecule fluorescent probes for simultaneous imaging of two bioactive molecules in live cells and in vivo
Frontiers of Chemical Science and Engineering (2022)
-
Gene therapy in Parkinson?s disease
Cell and Tissue Research (2004)
-
On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies
British Journal of Pharmacology (2003)
-
Gene therapy for experimental brain tumors using a xenogenic cell line engineered to secrete hIL-2
Journal of Neuro-oncology (2003)